Federica “Freddi” O’Brien

Ms. O’Brien is a veteran executive with 25 years of financial and operational leadership in biopharmaceutical, medical device, and technology companies and has held a variety of senior roles, including CFO, COO, Controller and Director of Financial Reporting, at companies ranging from nonclinical through commercial-stage, including Complexa Inc., Cerecor Inc., Cervilenz Inc., Cardiokine Inc., Barrier Therapeutics, Inc. and Infonautics, Inc. Ms. O’Brien spent over a decade in professional service accounting firms, most recently at Coopers & Lybrand (PricewaterhouseCoopers), where she was focused on high growth companies in multiple industries. She currently serves on the Board of Directors of TELA Bio, Inc. Ms. O’Brien received her Bachelor of Arts degree in Accounting from Rutgers University and is a Certified Public Accountant-Inactive, retired after thirty-eight years. Based on Ms. O’Brien’s financial expertise, as well as her depth of understanding in the biotechnology industry, the Board believes Ms. O’Brien has the appropriate set of skills to serve as a member of the Board.
Independent Director